Vaxxinity is a biotechnology company. Co.'s pipeline consists of five chronic disease product candidates including UB-311, which targets toxic forms of aggregated Ab in the brain to fight Alzheimer's Disease; UB-312, which targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's Disease and other synucleinopathies; an anti-tau product candidate that has the potential to address various neurodegenerative conditions; UB-313, which targets Calcitonin Gene-Related Peptide to fight migraines; and Anti-PCSK9, which targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events. We show 5 historical shares outstanding datapoints in our VAXX shares outstanding history coverage, used to compute VAXX market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing VAXX market cap history over the course of time is important for investors
interested in comparing VAXX's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of VAXX versus a peer is one thing; comparing
VAXX market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like VAXX can fluctuate over the course of history.
With this page we aim to empower investors researching VAXX by allowing them to research the VAXX market cap history. |
Free VAXX Email Alerts:
Video: The Importance of Market Cap
